FDA Approves First Interchangeable Biosimilar to Adalimumab, Plus a Combination Drug Approved
FDA Approves Cyltezo, an Interchangeable Biosimilar to Humira
A Dematologist’s Perspective on Choosing an Anti-Psoriatic Drug
FDA Approves Avacopan for the Treatment of ANCA-Associated Vasculitis
Guselkumab Promising in Patients with PsA
Live Varicella Zoster Vaccine Safe, Effective with TNF Inhibitors
Rituximab for Children with Lupus Nephritis
20 Years of RA Data: First-Line Biologic & Targeted Synthetic DMARD Trends
Insight into the Biosimilar Prescribing Habits of Rheumatologists
- 1
- 2
- 3
- …
- 34
- Next Page »